Introducing Prognos Health, the trailblazer in IT services and consulting, propelling the healthcare industry forward with its cutting-edge solutions. With an impressive $23M raised and a stellar lineup of investors including Marshall Wace, Labcorp, Red & Blue Ventures, Maywic Select Investments, Merck, Hikma Ventures, Cigna Healthcare, and Safeguard Scientifics, founder Scott Dunn is leading the charge in revolutionizing patient outcomes. Prognos Health empowers you to accelerate your path to clinical truth by harnessing the power of interoperable real-world data. By integrating de-identified patient data from multiple sources and harmonizing it at scale, Prognos Health puts invaluable insights at your fingertips. 

Their data marketplace offers a streamlined approach to license real-world data, eliminating the hassle of data ingestion and enabling you to dive straight into the analysis. With in-depth clinical lab and claims data spanning various therapeutic areas, Prognos Health provides unparalleled clinical insights and industry solutions. Whether you're a life sciences company in need of real-world data to support your commercialization efforts or seeking a comprehensive health data marketplace, Prognos Health is the partner of the future. Their precision, speed, and durability in delivering customizable and pre-certified data sets make them a force to be reckoned with. Experience the power of Prognos Health and unlock the potential of real-world data for improved patient outcomes.